WallStSmart
ZURA

Zura Bio Limited Class A Ordinary Shares

NASDAQ: ZURA · HEALTHCARE · BIOTECHNOLOGY

$4.75
-7.36% today

Updated 2026-06-05

Market cap
$351.06M
P/E ratio
P/S ratio
EPS (TTM)
$-1.09
Dividend yield
52W range
$1 – $7
Volume
0.8M

WallStSmart proprietary scores

31
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.3
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
1/9
Piotroski F-Score
Weak
1.0
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$15.67
+229.89%
12-Month target
Intrinsic (DCF)
Margin of safety
1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Altman Z 1.02 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-18.94M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-25.74M$-60.36M$-52.40M$-68.65M$-24.22M
EPS$-1.09
Free cash flow$-13.20M$-23.05M$-28.15M$-64.93M$-18.94M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
ZURA$351.06M314.33.05.05.3Avoid
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
UNH$343.21B545.35.54.75.5-26.61%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

Zura Bio Limited Class A Ordinary Shares trades at $4.75. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 1.02, it sits in the distress.

Frequently asked questions

What is Zura Bio Limited Class A Ordinary Shares's stock price?

Zura Bio Limited Class A Ordinary Shares (ZURA) trades at $4.75.

Is Zura Bio Limited Class A Ordinary Shares overvalued?

Zura Bio Limited Class A Ordinary Shares carries a Smart Value Score of 31/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Zura Bio Limited Class A Ordinary Shares (ZURA)?

The 12-month analyst consensus target is $15.67, about 229.9% above the current $4.75. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Zura Bio Limited Class A Ordinary Shares's Altman Z-Score is 1.02, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-34.78%
Beta0.09
50D MA$4.81
200D MA$4.61
Shares out0.09B
Float0.05B
Short ratio
Avg volume0.8M

Performance

1 week+0.00%
1 month-29.17%
3 months-44.89%
YTD-35.11%
1 year
3 years
5 years